These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 1452928)

  • 41. Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients.
    Ormerod JO; Arif S; Mukadam M; Evans JD; Beadle R; Fernandez BO; Bonser RS; Feelisch M; Madhani M; Frenneaux MP
    Circ Heart Fail; 2015 May; 8(3):565-71. PubMed ID: 25838311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A non-invasive evaluation of flosequinan on haemodynamics and exercise capacity in chronic congestive heart failure.
    Motro M; Freimark D; Feinberg MS; Wynne RD; King C; Schneeweiss A
    Int J Clin Pharmacol Res; 1993; 13(3):143-9. PubMed ID: 8225697
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between exogenous atrial natriuretic peptide and hemodynamics in dogs with congestive heart failure produced by experimental mitral regurgitation.
    Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
    J Vet Med Sci; 2001 Mar; 63(3):243-50. PubMed ID: 11307923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amlodipine therapy in congestive heart failure: hemodynamic and neurohormonal effects at rest and after treadmill exercise.
    Krombach RS; Clair MJ; Hendrick JW; Mukherjee R; Houck WV; Hebbar L; Kribbs SB; Dodd MG; Spinale FG
    Am J Cardiol; 1999 Aug; 84(4A):3L-15L. PubMed ID: 10480440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.
    Rubin SA; Tabak L
    J Am Coll Cardiol; 1985 Jun; 5(6):1422-7. PubMed ID: 3158690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.
    Magorien RD; Brown GP; Unverferth DV; Nelson S; Boudoulas H; Bambach D; Leier CV
    Circulation; 1982 Mar; 65(3):528-33. PubMed ID: 7055874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
    Martin JL; Likoff MJ; Janicki JS; Laskey WK; Hirshfeld JW; Weber KT
    J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term assessment of left ventricular function, coronary hemodynamics, and catecholamine balance in severe congestive heart failure after a single oral dose of milrinone.
    Piscione F; Jaski BE; Serruys PW
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):258-69. PubMed ID: 2452918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of atrial natriuretic factor on coronary hemodynamics and myocardial energetics in patients with heart failure.
    Herrmann HC; Palacios IF; Dec GW; Scheer JM; Fifer MA
    Am Heart J; 1988 Jun; 115(6):1232-8. PubMed ID: 2967626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate.
    Bersin RM; Wolfe C; Kwasman M; Lau D; Klinski C; Tanaka K; Khorrami P; Henderson GN; de Marco T; Chatterjee K
    J Am Coll Cardiol; 1994 Jun; 23(7):1617-24. PubMed ID: 8195522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
    Kiowski W; Erne P; Pfisterer M; Mueller J; Buehler FR; Burkart F
    Am J Cardiol; 1987 May; 59(12):1118-25. PubMed ID: 3578053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flosequinan does not affect systemic and regional vascular responses to simulated orthostatic stress in healthy volunteers.
    Duranteau J; Pussard E; Edouard A; Samii K; Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1992 Sep; 34(3):207-14. PubMed ID: 1389945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of flosequinan (BTS 49465) on myocardial oxygen consumption.
    Greenberg S; Touhey B; Paul J
    Am Heart J; 1990 Jun; 119(6):1355-66. PubMed ID: 2353621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
    Benotti JR; Grossman W; Braunwald E; Carabello BA
    Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
    Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
    Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
    Monrad ES; Baim DS; Smith HS; Lanoue A; Brauwald E; Grossman W
    Circulation; 1985 May; 71(5):972-9. PubMed ID: 3986984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flosequinan in chronic heart failure: how is exercise capacity improved?
    Banning AP; Ramsey MW; Jones EA; Evans W; Carolan G; Jones CH; Henderson AH
    Eur J Clin Pharmacol; 1996; 51(2):133-8. PubMed ID: 8911877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
    Maskin CS; Sinoway L; Chadwick B; Sonnenblick EH; Le Jemtel TH
    Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure.
    Rauch B; Zimmermann R; Kapp M; Haass M; Von Molitor S; Smolarz A; Neumann FJ; Kübler W; Dietz R; Tillmanns H
    Clin Cardiol; 1991 May; 14(5):386-95. PubMed ID: 2049889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of flosequinan on exercise capacity and cardiac function in patients with chronic mild heart failure: a double-blind placebo-controlled study.
    Hori M; Sato H; Ozaki H; Inoue M; Naka M; Fukunami M; Fukushima M; Kunisada K
    Heart Vessels; 1992; 7(3):133-40. PubMed ID: 1500398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.